Concepedia
Statistics
Publications
9
Citations
393
H-Index
Active since
2018
Affiliations
Tianjin Medical University(Current)
Ben-Gurion University of the Negev
Tianjin Tianhe Hospital
The University of Texas MD Anderson Cancer Center
Tianjin First Center Hospital
Shaolu Zhang is an author at Tianjin Medical University specializing in pharmacology, oncology, and molecular oncology.
Publications per year
2018–2024
BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair
Shaolu Zhang, Xin Peng, Xiaofei Li et al. · Cell Death and Disease · 2021 · 78 citations · Full text
Medicine, Oncology, Pharmacology +17
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
Yingying Wang, Qian Ma, Shaolu Zhang et al. · Frontiers in Pharmacology · 2020 · 64 citations · Full text
Medicine, Oncology, Pharmacology +15
Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair
Xin Peng, Shaolu Zhang, Yingying Wang et al. · Advanced Science · 2022 · 60 citations · Full text
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
Xin Peng, Shaolu Zhang, Wenhui Jiao et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 57 citations · Full text
Life Sciences, Oncology, Pharmacology +15
DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
Zhengming Wang, Yingying Wang, Shan Zhu et al. · Frontiers in Pharmacology · 2018 · 34 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 9